生物标志物 生物标志物
Catarina Tristão-Pereira1,2, David Fernando Aguillón Niño3, Ana Y Baena4
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
在自体主导的阿尔茨海默氏病 (AD) 中,用18F-氧葡萄糖 (FDG) PET测量的大脑葡萄糖低代谢反映了神经元损伤和反应性星病. 星病影响FDG-PET信号独立于神经退行,表明复杂的潜在机制.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 神经成像是一种神经成像.
背景情况:
- 大脑葡萄糖低代谢 (F-fluorodeoxyglucose PET) 是阿尔茨海默病 (AD) 的一个标志.
- FDG-PET变化区分痴呆症类型,但具有复杂的病理基础.
- 天体细胞对FDG-PET信号做出了重大贡献,消耗了大量的大脑能量.
研究的目的:
- 研究质纤维酸蛋白 (GFAP) 和神经丝光链 (NfL) 对自体主导AD的FDG-PET的差异性贡献.
- 确定天体细胞反应性和神经元损伤标志物和大脑代谢之间的关系.
主要方法:
- 包括40个Presenilin-1 E280A突变载体和37个来自COLBOS生物标志物研究的对照.
- 量化血GFAP和NfL;在自由冲浪者地区的加工FDG-PET吸收.
- 使用斯皮尔曼相关性,拉索回归和调解分析来评估生物标志物与FDG吸收的关联.
主要成果:
- 突变携带者比对照者显示出更高的血GFAP和NFL.
- 无论是GFAP还是NfL,都与载体的FDG吸收有负相关性,特别是在角-角区域和海马体.
- 血GFAP,但不是NfL,在拉索模型中仍然与全球FDG吸收有关,显示了直接影响.
结论:
- 在AD中的FDG-PET信号可能反映了反应性星病和神经元损伤.
- 反应性星病影响低代谢,独立于神经退行.
- 血管或神经炎症机制可能会导致低代谢和早期AD发作,需要谨慎的FDG-PET解释.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516